-
Featured
Nerve Transfer Boosts Recovery After Brachial Plexus Injury
For patients with brachial plexus injuries, a Mass General neurosurgeon is innovating nerve transfers that can restore function to paralyzed arms.
-
Featured
How Liquid Biopsy Could Improve Brain Tumor Treatment and Diagnoses
Mass General doctors are developing a liquid biopsy for brain tumors to reduce the need for invasive tissue biopsies.
-
Featured
Surviving Gliomas Through Antibodies and Vaccination
Immunotherapy for glioma is under active investigation, but tumor-associated immunosuppression is a major obstacle. A Mass General team studied an investigational monoclonal antibody in mice with glioma, alone and in combination with tumor cell vaccination.
-
Third-Generation CAR T-cell Therapy for Glioblastoma Is Effective in Animal Model
A new chimeric antigen receptor T-cell strategy for glioblastoma, developed at Massachusetts General Hospital and proven effective in mice, relies on co-culturing the T cells with artificial antigen-presenting cells that express co-stimulatory molecules, to boost T-cell activation and persistence.
-
Using Stem Cells to Treat Movement Disorders
In this video, JeffreySchweitzer, MD, PhD, discusses his research using stem cell technology to restore normal function in patients with movement disorders. He believes this technology may be able to improve outcomes for patients with tremor, Parkinson's disease and dystonia.
-
Novel Model of Recurrent Glioblastoma May Facilitate Development of Targeted Therapies
Neurosurgeons and neuro-oncologists at Massachusetts General Hospital have published the first report that documents loss of receptor tyrosine kinase gene amplification in glioblastoma after targeted therapy—and describes a novel preclinical model for studying these molecular changes.
Neurosurgery contributors
-
Aman B. Patel, MD
Director of Cerebrovascular and Endovascular Neurosurgery, Co-Director of the Neuroendovascular Program
Recent Article
Using Data to Predict Which Aneurysms May Burst
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Third-Generation CAR T-cell Therapy for Glioblastoma Is Effective in Animal Model
-
Brian V. Nahed, MD, MSc
Neurosurgical Oncology / Brain Tumor Surgeon / Mass General Brain Tumor Center, Neurosurgical Spinal Disorders, Associate Professor, Harvard Medical School
Associate Director Mass General Neurosurgery ProgramRecent Article
The Mass General Neurosurgery Mission
-
-
James D. Rabinov, MD
Neurosurgeon
Recent Article
Diagnosing, Treating and Caring for Patients with Aneurysms: Q&A with James D. Rabinov, MD
-
Jean V. Coumans, MD
Neurosurgeon
Recent Article
Sacral Slope Measurement Helpful for Determining if Fusion Surgery Needed for Spondylolisthesis
-
Jeffrey S. Schweitzer, MD, PhD
Neurosurgeon
Recent Article
Using Stem Cells to Treat Movement Disorders
-
John H. Shin, MD
Director, Metastatic Spine Oncology and Spinal Deformity Surgery (Mass General Cancer Center), Spinal Reconstruction Surgery
Recent Article
The Mass General Neurosurgery Mission
-
-
Lawrence Borges, MD
Director, Neurosurgical Spine Center
Recent Article
Treating Intradural Spinal Tumors
-
-
William E. Butler, MD
Neurosurgeon
Recent Article
Recurrent Basilar Tip Pseudoaneurysm Treated Successfully with Flow Diversion
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Triple Immunotherapy Completely Eradicates Glioma in Animal Models
-
Ziv Williams, MD
Associate Professor in Neurosurgery
Recent Article
Long-Term Visual Memory Has a Role in Suppressing Learning
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
